Topics
January/February 2015 | Special Report: Diabetic Microvascular Complications
Bariatric Surgery Does Not Prevent Progression of Diabetic Retinopathy
A study found no advantage of surgery over intensive medical therapy in diabetic retinopathy development at 2 years.
Rishi P. Singh, MD
October 16, 2026
Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
October 15, 2026
Study Finds Rising Demand for Emergency Ophthalmology Consultations Across US Academic Centers
Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in DME
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
